What is the Relationship among Microrna-181, Epithelial Cell-Adhesion Molecule (epcam) and Beta-Catenin in Hepatic Cancer Stem Cells

Ji-Peng Li,Jian-Yong Zheng,Jian-Jun Du,Rui Zhang,An-Gang Yang

DOI: https://doi.org/10.1002/hep.23356

IF: 17.298

2009-01-01

Hepatology

Abstract:combination of four factors (Oct3/4, Sox2, NANOG [Nanog homeobox], and LIN28 [lin-28 homolog]) is also sufficient to induce pluripotent stem cells from human somatic cells,4 indicating that more genes are involved in the establishment or maintenance of pluripotency. In this case, the therapy of HCC directing to one or several of these genes may be insufficient to achieve satisfactory efficacy. On the other hand, a recent report by Gupta et al. showed that salinomycin might selectively eliminate breast CSCs and inhibit metastasis by inducing the differentiation of CSCs. They also suggest that it is preferable to treat cancer using agents that target both the CSCs and non-CSCs, because non-CSCs might transform into CSCs and thus eradication of CSCs alone may not obtain complete regression of an established tumor.5 Interestingly, our study indicated that HNF4 could induce the differentiation of both hepatoma cells and its CSCs. The suppression of CSCs was accompanied by the inhibition of a cluster of genes which contribute to the pluripotency of human stem cells, including -catenin, Oct3/4, SMO(smoothened homolog), Bmi, Sox2, NANOG, c-Myc, Klf4, LIN28, and ESG1 (enhancer of split groucho 1).3 More recently, we also demonstrated that upregulation of HNF4 remarkably ameliorated hepatic fibrosis6 and prevented the development of HCC in rats accompanied by the revision of epithelial-mesenchymal transition (unpublished data). Thus, we believe that differentiation therapy with HNF4 , a central regulator for hepatocyte differentiation, might be an ideal strategy for the treatment of human HCC. Moreover, this strategy may be extended to other cancer types through the induction of differentiation using their corresponding key transcription factors. CHUAN YIN WEI-FEN XIE Department of Gastroenterology Changzheng Hospital, Second Military Medical University Shanghai, China